In the BioHarmony Drug Report Database

"Preview" Icon

Ezogabine

Potiga (ezogabine) is a small molecule pharmaceutical. Ezogabine was first approved as Potiga on 2011-06-10. It is used to treat partial epilepsies in the USA. The pharmaceutical is active against potassium voltage-gated channel subfamily KQT member 3, potassium voltage-gated channel subfamily KQT member 2, potassium voltage-gated channel subfamily KQT member 4, and potassium voltage-gated channel subfamily KQT member 5.

 

Trade Name

 

Potiga
 

Common Name

 

ezogabine
 

ChEMBL ID

 

CHEMBL41355
 

Indication

 

partial epilepsies
 

Drug Class

 

Gabamimetics

Image (chem structure or protein)

Ezogabine structure rendering